Market Cap 239.76M
Revenue (ttm) 0.00
Net Income (ttm) -15.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 855,299
Avg Vol 487,302
Day's Range N/A - N/A
Shares Out 237.38M
Stochastic %K 21%
Beta 1.63
Analysts Sell
Price Target $13.00

Company Profile

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis pat...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 2 620 8072
Address:
14 Einstein Street, Ness Ziona, Israel
Safran18
Safran18 Sep. 11 at 8:15 PM
$ENLV Do you even vote ??
1 · Reply
Nesabbah
Nesabbah Sep. 11 at 8:02 PM
$ENLV every day. Green all day then last second drops red
0 · Reply
Ygershon
Ygershon Sep. 11 at 12:30 PM
$ENLV today we start the run until 5$
1 · Reply
topstockalerts
topstockalerts Sep. 10 at 1:09 AM
After Hours Top Gainers PT2 $JYD $IPDN $ENLV $AJG $ABNB
0 · Reply
Brilloballs
Brilloballs Sep. 8 at 11:04 AM
$ENLV All the reverse split did was completely destroy our investments. My price per share is now $35 with another split on the way. It's almost like it was their plan.🇮🇱
0 · Reply
Seekthegain
Seekthegain Sep. 5 at 10:42 PM
$ENLV Over the trailing twelve months (TTM), these digital asset paper gains have vaulted Enlivex's recorded net income to $1.24 billion, leading to an anomalous Diluted EPS of $362.43—figures entirely uncharacteristic of a standard clinical-stage immunotherapy firm. [1] (https://www.investing.com/news/company-news/enlivex-reports-116-billion-in-rain-token-holdings-93CH-4714253), [2] (https://ca.finance.yahoo.com/quote/ENLV/), [3] (https://www.theglobeandmail.com/investing/markets/stocks/ENLV-Q/pressreleases/3575293/enlivex-highlights-622-surge-in-rain-protocol-trading-volume-to-860-million/)
1 · Reply
Seekthegain
Seekthegain Sep. 5 at 4:36 PM
$ENLV the market value of the RAIN token holdings is explicitly included in the overall treasury valuation and net asset value (NAV) per share calculations of Enlivex Ltd. (NASDAQ: ENLV). [1] (https://www.theglobeandmail.com/investing/markets/stocks/ENLV-Q/pressreleases/3381591/enlivex-reveals-1-1-billion-rain-token-treasury-and-66-16-nav-per-share/), [2] (https://www.investing.com/news/company-news/gate-exchange-lists-enlivex-treasury-asset-rain-token-93CH-4758032)Enlivex operates a prediction-markets treasury strategy and uses a mark-to-market approach to value its massive holding of RAIN tokens. For instance, the company has regularly reported updates—such as valuing its roughly 79.5 billion RAIN tokens at over $1.1 billion—which directly factor into its calculated net asset value per ordinary share. You can read the official financial breakdowns on the Enlivex Investor Relations portal. [1] (https://www.investing.com/news/company-news/enlivex-reports-116-billion-in-rain-token-holdings-93CH-4714253), [2] (https://intellectia.ai/news/stock/enlivex-reports-net-asset-value-of-6616-per-share), [3] (https://investors.enlivex.com/press-releases/enlivex-treasury-portfolio-update-rain-holdings-valued-at-approximately-1-16-billion-rain-foundation-appoints-industry-leaders-to-advisory-board/), [4] (https://www.theglobeandmail.com/investing/markets/stocks/ENLV-Q/pressreleases/3381591/enlivex-reveals-1-1-billion-rain-token-treasury-and-66-16-nav-per-share/)
0 · Reply
Seekthegain
Seekthegain Sep. 5 at 2:46 PM
$ENLV Rain token is up 30% over the last 30 days and 3950% for the trailing 12 months. Ond day people will understand this. Holding
2 · Reply
Pacho_Unlimited1
Pacho_Unlimited1 Sep. 4 at 8:33 PM
$ENLV sad….
2 · Reply
Alex1710
Alex1710 Sep. 3 at 10:42 PM
$ENLV very comfortable with my short position.
0 · Reply
Latest News on ENLV
Enlivex Registration statement: Registration filing

Aug 6, 2026, 8:00 AM EDT - 5 weeks ago

Enlivex Registration statement: Registration filing


Enlivex Transcript: Study update

Jul 30, 2026, 10:00 AM EDT - 6 weeks ago

Enlivex Transcript: Study update


Enlivex Therapeutics announces $400M private placement

2026-07-28T12:36:35.000Z - 6 weeks ago

Enlivex Therapeutics announces $400M private placement


Enlivex Announces $400,000,000 Private Placement

Jul 28, 2026, 8:00 AM EDT - 6 weeks ago

Enlivex Announces $400,000,000 Private Placement


Enlivex Therapeutics trading halted, news pending

2026-07-08T23:50:17.000Z - 2 months ago

Enlivex Therapeutics trading halted, news pending


Enlivex Therapeutics announces 1-for-15 reverse split

2026-07-07T12:36:17.000Z - 2 months ago

Enlivex Therapeutics announces 1-for-15 reverse split


Enlivex Slides: Investor presentation

Jun 24, 2026, 9:00 AM EDT - 2 months ago

Enlivex Slides: Investor presentation


Enlivex Therapeutics announces issuance of Australian patent

2026-06-15T13:01:02.000Z - 2 months ago

Enlivex Therapeutics announces issuance of Australian patent


Enlivex Slides: Investor presentation

Jun 15, 2026, 7:00 AM EDT - 2 months ago

Enlivex Slides: Investor presentation


Enlivex Therapeutics doses first patient in Allocetra trial

2026-05-18T12:17:18.000Z - 3 months ago

Enlivex Therapeutics doses first patient in Allocetra trial


Enlivex Registration statement: Registration filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Enlivex Registration statement: Registration filing


Ondo Global Markets Tokenizes Enlivex's Ordinary Shares

Apr 8, 2026, 8:30 AM EDT - 5 months ago

Ondo Global Markets Tokenizes Enlivex's Ordinary Shares


Enlivex Earnings Call Transcript: Q4 2025

Mar 25, 2026, 9:00 AM EDT - 5 months ago

Enlivex Earnings Call Transcript: Q4 2025


Enlivex Annual report: Q4 2025

Mar 25, 2026, 9:00 AM EDT - 5 months ago

Enlivex Annual report: Q4 2025


Enlivex Quarterly report: Q4 2025

Mar 25, 2026, 9:00 AM EDT - 5 months ago

Enlivex Quarterly report: Q4 2025


Enlivex Slides: Investor presentation

Mar 24, 2026, 8:00 AM EDT - 5 months ago

Enlivex Slides: Investor presentation


Enlivex Therapeutics management to meet virtually with BTIG

2026-02-18T17:40:32.000Z - 6 months ago

Enlivex Therapeutics management to meet virtually with BTIG


Enlivex Therapeutics shares to trade exclusively on Nasdaq

2026-01-23T13:05:21.000Z - 7 months ago

Enlivex Therapeutics shares to trade exclusively on Nasdaq


Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

Jan 23, 2026, 8:00 AM EST - 7 months ago

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq


Enlivex Registration statement: Registration Filing

Dec 23, 2025, 7:00 AM EST - 8 months ago

Enlivex Registration statement: Registration Filing


Enlivex Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 10 months ago

Enlivex Quarterly report: Q3 2025


Enlivex Quarterly report: Q2 2025

Aug 29, 2025, 4:00 PM EDT - 1 year ago

Enlivex Quarterly report: Q2 2025


Enlivex Transcript: Status Update

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Enlivex Transcript: Status Update


Enlivex Press release: Status Update

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Enlivex Press release: Status Update


Enlivex Slides: Company Presentation

Jun 3, 2025, 6:00 PM EDT - 1 year ago

Enlivex Slides: Company Presentation


Enlivex Earnings release: Q1 2025

May 29, 2025, 6:00 PM EDT - 1 year ago

Enlivex Earnings release: Q1 2025


Enlivex Selected to Present at Israeli BioMed 2025 Conference

May 20, 2025, 8:00 AM EDT - 1 year ago

Enlivex Selected to Present at Israeli BioMed 2025 Conference


Enlivex Registration statement: Registration Filing

May 2, 2025, 8:00 AM EDT - 1 year ago

Enlivex Registration statement: Registration Filing


Enlivex Annual report: Q4 2024

Apr 29, 2025, 6:00 PM EDT - 1 year ago

Enlivex Annual report: Q4 2024


Enlivex Slides: Company Presentation

Mar 6, 2025, 7:00 AM EST - 1 year ago

Enlivex Slides: Company Presentation


Safran18
Safran18 Sep. 11 at 8:15 PM
$ENLV Do you even vote ??
1 · Reply
Nesabbah
Nesabbah Sep. 11 at 8:02 PM
$ENLV every day. Green all day then last second drops red
0 · Reply
Ygershon
Ygershon Sep. 11 at 12:30 PM
$ENLV today we start the run until 5$
1 · Reply
topstockalerts
topstockalerts Sep. 10 at 1:09 AM
After Hours Top Gainers PT2 $JYD $IPDN $ENLV $AJG $ABNB
0 · Reply
Brilloballs
Brilloballs Sep. 8 at 11:04 AM
$ENLV All the reverse split did was completely destroy our investments. My price per share is now $35 with another split on the way. It's almost like it was their plan.🇮🇱
0 · Reply
Seekthegain
Seekthegain Sep. 5 at 10:42 PM
$ENLV Over the trailing twelve months (TTM), these digital asset paper gains have vaulted Enlivex's recorded net income to $1.24 billion, leading to an anomalous Diluted EPS of $362.43—figures entirely uncharacteristic of a standard clinical-stage immunotherapy firm. [1] (https://www.investing.com/news/company-news/enlivex-reports-116-billion-in-rain-token-holdings-93CH-4714253), [2] (https://ca.finance.yahoo.com/quote/ENLV/), [3] (https://www.theglobeandmail.com/investing/markets/stocks/ENLV-Q/pressreleases/3575293/enlivex-highlights-622-surge-in-rain-protocol-trading-volume-to-860-million/)
1 · Reply
Seekthegain
Seekthegain Sep. 5 at 4:36 PM
$ENLV the market value of the RAIN token holdings is explicitly included in the overall treasury valuation and net asset value (NAV) per share calculations of Enlivex Ltd. (NASDAQ: ENLV). [1] (https://www.theglobeandmail.com/investing/markets/stocks/ENLV-Q/pressreleases/3381591/enlivex-reveals-1-1-billion-rain-token-treasury-and-66-16-nav-per-share/), [2] (https://www.investing.com/news/company-news/gate-exchange-lists-enlivex-treasury-asset-rain-token-93CH-4758032)Enlivex operates a prediction-markets treasury strategy and uses a mark-to-market approach to value its massive holding of RAIN tokens. For instance, the company has regularly reported updates—such as valuing its roughly 79.5 billion RAIN tokens at over $1.1 billion—which directly factor into its calculated net asset value per ordinary share. You can read the official financial breakdowns on the Enlivex Investor Relations portal. [1] (https://www.investing.com/news/company-news/enlivex-reports-116-billion-in-rain-token-holdings-93CH-4714253), [2] (https://intellectia.ai/news/stock/enlivex-reports-net-asset-value-of-6616-per-share), [3] (https://investors.enlivex.com/press-releases/enlivex-treasury-portfolio-update-rain-holdings-valued-at-approximately-1-16-billion-rain-foundation-appoints-industry-leaders-to-advisory-board/), [4] (https://www.theglobeandmail.com/investing/markets/stocks/ENLV-Q/pressreleases/3381591/enlivex-reveals-1-1-billion-rain-token-treasury-and-66-16-nav-per-share/)
0 · Reply
Seekthegain
Seekthegain Sep. 5 at 2:46 PM
$ENLV Rain token is up 30% over the last 30 days and 3950% for the trailing 12 months. Ond day people will understand this. Holding
2 · Reply
Pacho_Unlimited1
Pacho_Unlimited1 Sep. 4 at 8:33 PM
$ENLV sad….
2 · Reply
Alex1710
Alex1710 Sep. 3 at 10:42 PM
$ENLV very comfortable with my short position.
0 · Reply
Roraon
Roraon Sep. 3 at 10:05 PM
$ENLV this is almost as bad as ADTX.
0 · Reply
CoachHendo
CoachHendo Sep. 3 at 8:30 AM
$ENLV adding!
0 · Reply
Seekthegain
Seekthegain Aug. 31 at 3:28 PM
$ENLV taking a flyer on this. If he was a one star I wouldn't consider but when a five star analyst gives a target of $80 I'll play. First 2500 shares at $1.25 and I'll go from there
0 · Reply
VintageCulture
VintageCulture Aug. 29 at 4:40 AM
Watch NCRA 1000% runner potential, 0 shares to short 500% CTB $13 fair value MASSIVE MICRON TIES one of the most undervalued setups you will find $TROO $LCFY $INKT $ENLV 😏❤️❤️😏❤️
1 · Reply
FST3
FST3 Aug. 28 at 2:06 PM
$ENLV shorts will pay soon. RMAT designation and the value is basically cash, which tells you it's manipulated. The volume also does, the minute the SP goes up, it gets beaten down...it's so obvious. Rain Token slowly increasing and diversifying the amount of users. It's basically trading at 10 cents a share.....put this perspective, it was $2 a share when Rain token was below 1 cent.....look at the history. Things look bad until they are not. Currently there are only 16.83M shares outstanding. If trials succesful, the SP will go beyond $100.
1 · Reply
Sensore
Sensore Aug. 26 at 7:57 PM
0 · Reply
Pnomene
Pnomene Aug. 25 at 10:42 PM
$ENLV Rain token up 23% 🫪
0 · Reply
DeltaDrifterS
DeltaDrifterS Aug. 25 at 2:10 PM
$ENLV Phase 2b knee-OA trial underway with first U.S. patient dosed…
1 · Reply
DaVinciiKnows
DaVinciiKnows Aug. 24 at 12:51 AM
$CYCU $STKH $LVWR $ENLV $MWC Let’s see what this week brings
0 · Reply
mbelect
mbelect Aug. 20 at 10:11 PM
$ENLV maybe the next reverse split should be 1:100. it was too fast that this stock ( shit) is back to 1. where is that piece of shit Raju.
1 · Reply
jacksonjohn750
jacksonjohn750 Aug. 20 at 3:02 PM
$ENLV Yup
0 · Reply
jacksonjohn750
jacksonjohn750 Aug. 20 at 2:57 PM
$ENLV Next PR: we bought another btc!! LOL
0 · Reply